242 related articles for article (PubMed ID: 37165929)
1. Nucleophosmin promotes lung adenocarcinoma cell proliferation, migration and invasion by activating the EGFR/MAPK signaling pathway.
Li M; Wu R; Zhu D; Wang L; Liu S; Wang R; Deng C; Zhang S; Chen M; Lu R; Zhu H; Mo M; Luo Z
Oncol Rep; 2023 Jun; 49(6):. PubMed ID: 37165929
[TBL] [Abstract][Full Text] [Related]
2. CD73 (NT5E) Promotes the Proliferation and Metastasis of Lung Adenocarcinoma through the EGFR/AKT/mTOR Pathway.
Zhang H; Cao Y; Tang J; Wang R
Biomed Res Int; 2022; 2022():9944847. PubMed ID: 35813221
[TBL] [Abstract][Full Text] [Related]
3. PAR2 promotes tumor-associated angiogenesis in lung adenocarcinoma through activating EGFR pathway.
Li Y; Huang H; Chen X; Yu N; Ye X; Chen L; Huang Z
Tissue Cell; 2022 Dec; 79():101918. PubMed ID: 36148733
[TBL] [Abstract][Full Text] [Related]
4. Plakophilin-2 accelerates cell proliferation and migration through activating EGFR signaling in lung adenocarcinoma.
Hao XL; Tian Z; Han F; Chen JP; Gao LY; Liu JY
Pathol Res Pract; 2019 Jul; 215(7):152438. PubMed ID: 31126818
[TBL] [Abstract][Full Text] [Related]
5. STAMBP promotes lung adenocarcinoma metastasis by regulating the EGFR/MAPK signaling pathway.
Xu H; Yang X; Xuan X; Wu D; Zhang J; Xu X; Zhao Y; Ma C; Li D
Neoplasia; 2021 Jun; 23(6):607-623. PubMed ID: 34102455
[TBL] [Abstract][Full Text] [Related]
6. EphA10 drives tumor progression and immune evasion by regulating the MAPK/ERK cascade in lung adenocarcinoma.
Zhao W; Liu L; Li X; Xu S
Int Immunopharmacol; 2022 Sep; 110():109031. PubMed ID: 35839564
[TBL] [Abstract][Full Text] [Related]
7. Knockdown of HE4 suppresses tumor growth and invasiveness in lung adenocarcinoma through regulation of EGFR signaling.
Zhang Y; Yang W; Han X; Qiao Y; Wang H; Chen T; Li T; Ou WB
Oncol Res; 2024; 32(6):1119-1128. PubMed ID: 38827327
[TBL] [Abstract][Full Text] [Related]
8. PPP1R14D promotes the proliferation, migration and invasion of lung adenocarcinoma via the PKCα/BRAF/MEK/ERK signaling pathway.
Cao H; Wang Z; Wang Y; Ye L; Li R; Xue Y; Li K; Di T; Li T; Fan Z; Liu Y; Guo J; Yao H; Ge C
Int J Oncol; 2022 Dec; 61(6):. PubMed ID: 36263632
[TBL] [Abstract][Full Text] [Related]
9. Silencing of CD147 inhibits cell proliferation, migration, invasion, lipid metabolism dysregulation and promotes apoptosis in lung adenocarcinoma via blocking the Rap1 signaling pathway.
Zhang N; Liu Z; Lai X; Liu S; Wang Y
Respir Res; 2023 Oct; 24(1):253. PubMed ID: 37880644
[TBL] [Abstract][Full Text] [Related]
10. NPM1 Is a Prognostic Biomarker Involved in Immune Infiltration of Lung Adenocarcinoma and Associated With m6A Modification and Glycolysis.
Liu XS; Zhou LM; Yuan LL; Gao Y; Kui XY; Liu XY; Pei ZJ
Front Immunol; 2021; 12():724741. PubMed ID: 34335635
[TBL] [Abstract][Full Text] [Related]
11. Junctional adhesion molecule-like protein promotes tumor progression via the Wnt/β-catenin signaling pathway in lung adenocarcinoma.
Wu Q; Li R; Wang QX; Zhang MY; Liu TT; Qu YQ
J Transl Med; 2022 Jun; 20(1):260. PubMed ID: 35672776
[TBL] [Abstract][Full Text] [Related]
12. KANK3 mediates the p38 MAPK pathway to regulate the proliferation and invasion of lung adenocarcinoma cells.
Dai Z; Xie B; Yang B; Chen X; Hu C; Chen Q
Tissue Cell; 2023 Feb; 80():101974. PubMed ID: 36463587
[TBL] [Abstract][Full Text] [Related]
13. C1orf74 positively regulates the EGFR/AKT/mTORC1 signaling in lung adenocarcinoma cells.
Guo J; Li A; Guo R; He Q; Wu Y; Gou Y; Jin J; Huang G
PeerJ; 2022; 10():e13908. PubMed ID: 36032960
[TBL] [Abstract][Full Text] [Related]
14. Loss of ARID1A expression promotes lung adenocarcinoma metastasis and predicts a poor prognosis.
Sun D; Zhu Y; Zhao H; Bian T; Li T; Liu K; Feng L; Li H; Hou H
Cell Oncol (Dordr); 2021 Oct; 44(5):1019-1034. PubMed ID: 34109546
[TBL] [Abstract][Full Text] [Related]
15. Nucleophosmin Mutants Promote Adhesion, Migration and Invasion of Human Leukemia THP-1 Cells through MMPs Up-regulation via Ras/ERK MAPK Signaling.
Xian J; Shao H; Chen X; Zhang S; Quan J; Zou Q; Jin H; Zhang L
Int J Biol Sci; 2016; 12(2):144-55. PubMed ID: 26884713
[TBL] [Abstract][Full Text] [Related]
16. CCNE1 Promotes Progression and is Associated with Poor Prognosis in Lung Adenocarcinoma.
Ma G; Yang L; Dong J; Zhang L
Curr Pharm Biotechnol; 2022; 23(9):1168-1178. PubMed ID: 34792009
[TBL] [Abstract][Full Text] [Related]
17. DLC1 inhibits lung adenocarcinoma cell proliferation, migration and invasion via regulating MAPK signaling pathway.
Niu N; Ma X; Liu H; Zhao J; Lu C; Yang F; Qi W
Exp Lung Res; 2021; 47(4):173-182. PubMed ID: 33678109
[TBL] [Abstract][Full Text] [Related]
18. TPI1 promotes MAPK/ERK-induced EMT, cell migration and invasion in lung adenocarcinoma.
Li Y; Pan B; Zhang F; Jia X; Zhu X; Tong X; Zhao J; Li C
Thorac Cancer; 2024 Feb; 15(4):327-338. PubMed ID: 38130074
[TBL] [Abstract][Full Text] [Related]
19. GLUT1 promotes cell proliferation via binds and stabilizes phosphorylated EGFR in lung adenocarcinoma.
Zhou Z; Li Y; Chen S; Xie Z; Du Y; Liu Y; Shi Y; Lin X; Zeng X; Zhao H; Chen G
Cell Commun Signal; 2024 Jun; 22(1):303. PubMed ID: 38831321
[TBL] [Abstract][Full Text] [Related]
20. Synaptotagmin 12 (SYT12) Gene Expression Promotes Cell Proliferation and Progression of Lung Adenocarcinoma and Involves the Phosphoinositide 3-Kinase (PI3K)/AKT/Mammalian Target of Rapamycin (mTOR) Pathway.
Liu K; Luo J; Shao C; Ren Z; Sun S; Zhu Y; Zhou H; Jiang Z; Li X; Gu W; Xu Y; Qiang Y; Ren B; Xu L; Wu H; Shen Y
Med Sci Monit; 2020 Feb; 26():e920351. PubMed ID: 32108133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]